The document describes a new insulin pump called the μ-Pump developed by Modular Medical to simplify diabetes management and make insulin therapy more affordable and accessible. It provides details on the founding team and their backgrounds, outlines solutions for both a basic and more sophisticated insulin pump system, and discusses product features, specifications, the clinical need for improved insulin delivery devices, business model, funding needs, and contact information. The company is seeking $450,000 to fund further product development, hiring, office space, and marketing for an initial beta launch.
2. Founding team
Alexander Senkevich
CEO
Responsible for development strategies, finance.
Launched 3 of his successful projects (service
for factoring operations, microcredit, scoring)
Mikhail Zeppelin
CT
15 years of experience developing devices
and more than 5 years in medical care developing
Ivan Nelybov
CE
4 years of experience in development MISRA
Klim Todrik
Senior developer
Product development in IT, experience
in implementing 3 projects.
Management of the IT structure.
Arsen Zanibek
Senior Designer
One of the TOP best developers,
responsible for technical part
Murobac Salieva
Marketing Manager
Key team member in 2 acquisitions
within one year
We have background, proven track record and vision to succees
4. Our Mission
At Modular Medical, our mission is to expand access
to high quality, modern diabetes care by taking
insulin pump delivery systems from a specialty
market to a mass market.
Our Vision
We aspire to develop technology that liberates
and empowers people to improve their health
and well-being and take back more of their lives.
Technology should simplify your life and make it better,
not to add new problems and new to do lists
It’s Time To change
Specialty products can be expensive, complex,
and have difficult learning curves.
Mass market products must be easy to afford,
easy to learn, easy to take home, and easy to use
5. SOLUTIONS
Designed to make easy.
adoption
μ-Pump ™
Our new and most sophisticated insulin pump system
helps users reach the glycemic consensus goals.
The system offers:
Ergonomically drip-like appearance, no external tubes
Exchangeable reservoir with integrated cannule block
Insulin injecting mechanism based on watch
mechanism with high accuracy and innovation power
management
Smartwatch and Smartphone control
Setter kit includes automatic injector system
with set system
OneMove™
6. SIMPLE & Discreet
Insulin Management System is suitable for all ages
and all activities. It is easy to use in your daily life
and it has only 2 parts.
Simple system setting without
extern device (OneMove ™)
7. Technical
Specifications
Watch type mechanism
Build-in Rechargeable Battery
Wireless control from Smartwatch or Smartphone
via BLE
Selectable insulin type, fillable or branded & filled
cartridge
OneMove™ system installation
8. Features
Our solutions work because:
Reusable small body pump
Replacement consumable cartridges
Free choice of insulin
Tank size
Automated insulin delivery controlled by phone or smartwatch
Few parts in consumable cartridges
Includes 2 pumps + charger
The pump mechanism uses the achievements of watchmakers
BLE technology - basic control from smartwatch or smartphone
Up to 72 hours of single pump operation
Ability to charge from Power Bank via USB Type-C with QC 3.0 support
Eco friendly
9. There are individuals with Type 1 Diabetes in the US.
require daily insulin injection.
Only an insulin pump.
1.6 million
100% of patient population
1 out of 3 currently use
An Unmet Need in Type 1 Diabetes Care
32%
of the population utilizes insulin pumps
for diabetes management
68%
of the population rely on multiple
daily injections for diabetes management
30%of the market are almost pumpers. They would go on pump if it were
less expensive, time consuming and technically intimidating. $ 1.9 bn
10. Insulin market size 2020 to 2030 (USD Billion) Insulin market size in usa
Market size
The global Insulin Pump Market is grow from
in 2022 to by 2029
in the forecast period, 2022-2029
$4.57 billion $13.17 billion
CAGR of 16.3%
TAM
$ 4.85 B
SAM
$ 2.35 B
SOM
$ 235 M
11. Key players
he global Insulin Pump Market is grow from
$4.57 billion in 2022 to $13.17 billion by 2029
CAGR of 16.3%
in the forecast period, 2022-2029
Medtronics Rouche Insulet μ-Pump
13. Business model
Freemium
starter-kit
+ demo-kit with expendable
materials
expendable materials are
purchased by subscription
or in pharmacies
Pump is given to clients for free (starter kit) with expendable materials demo kit.
After this users buy expendable materials directly.
Reservoir is included in expandable materials package.
Reservoir can be filled by branded insulin or by user’s insulin, for this expendable
material includes tools for filling insulin.
Expendable materials user box includes 10 pcs.
This model includes pump change for new one with subscription and life-time warranty.
Direct sales
insulin pump
expendable
materials
*Estimated 350,000 people in the US use insulin pumps today
14. We are looking for
$ 450 000
Product dev
$ 250 K
Mechanics improvemen
Development of consumables for installation
in productio
Prototype productio
Preparation for testing and sertificatio
Production & Marketin
Software development
New hires
$ 150 K
Hire key people in the foolowing fields
I
Engineerin
Marketing
Office & other
$ 50 K
Find great location for 10 person sta
Monthly payments for IT service
Beta launch promo campaign on the relevant
blogs, media, websites etc.
15. See you on board
u-pump.com
investors@u-pump.com
+1 610 244 1396